Page last updated: 2024-10-22

amlodipine and Colonic Neoplasms

amlodipine has been researched along with Colonic Neoplasms in 1 studies

Amlodipine: A long-acting dihydropyridine calcium channel blocker. It is effective in the treatment of ANGINA PECTORIS and HYPERTENSION.
amlodipine : A fully substituted dialkyl 1,4-dihydropyridine-3,5-dicarboxylate derivative, which is used for the treatment of hypertension, chronic stable angina and confirmed or suspected vasospastic angina.

Colonic Neoplasms: Tumors or cancer of the COLON.

Research Excerpts

ExcerptRelevanceReference
"Regorafenib is a multikinase inhibitor."5.72Amlodipine improves the outcomes of regorafenib in metastatic colorectal cancer. ( Alandağ, C; Karaman, E; Yüce, E, 2022)
"Regorafenib is a multikinase inhibitor."1.72Amlodipine improves the outcomes of regorafenib in metastatic colorectal cancer. ( Alandağ, C; Karaman, E; Yüce, E, 2022)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Alandağ, C1
Karaman, E1
Yüce, E1

Other Studies

1 other study available for amlodipine and Colonic Neoplasms

ArticleYear
Amlodipine improves the outcomes of regorafenib in metastatic colorectal cancer.
    Anti-cancer drugs, 2022, 04-01, Volume: 33, Issue:4

    Topics: Amlodipine; Colonic Neoplasms; Colorectal Neoplasms; Humans; Liver Neoplasms; Phenylurea Compounds;

2022